Blueprint Medicines Statistics
Total Valuation
BPMC has a market cap or net worth of $5.73 billion. The enterprise value is $5.58 billion.
Important Dates
The next estimated earnings date is Thursday, February 13, 2025, before market open.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BPMC has 63.53 million shares outstanding. The number of shares has increased by 3.11% in one year.
| Current Share Class | 63.53M |
| Shares Outstanding | 63.53M |
| Shares Change (YoY) | +3.11% |
| Shares Change (QoQ) | +0.84% |
| Owned by Insiders (%) | 1.07% |
| Owned by Institutions (%) | 104.10% |
| Float | 62.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.90 |
| Forward PS | 8.58 |
| PB Ratio | 18.27 |
| P/TBV Ratio | 18.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.84 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.32, with a Debt / Equity ratio of 2.34.
| Current Ratio | 3.32 |
| Quick Ratio | 3.10 |
| Debt / Equity | 2.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.49 |
Financial Efficiency
Return on equity (ROE) is -49.65% and return on invested capital (ROIC) is -17.05%.
| Return on Equity (ROE) | -49.65% |
| Return on Assets (ROA) | -14.97% |
| Return on Capital (ROIC) | -17.05% |
| Revenue Per Employee | $663,229 |
| Profits Per Employee | -$195,495 |
| Employee Count | 655 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 0.89 |
Taxes
In the past 12 months, BPMC has paid $615,000 in taxes.
| Income Tax | 615,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.48% in the last 52 weeks. The beta is 0.59, so BPMC's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | +2.48% |
| 50-Day Moving Average | 92.35 |
| 200-Day Moving Average | 96.69 |
| Relative Strength Index (RSI) | 42.10 |
| Average Volume (20 Days) | 667,767 |
Short Selling Information
The latest short interest is 4.19 million, so 6.59% of the outstanding shares have been sold short.
| Short Interest | 4.19M |
| Short Previous Month | 3.91M |
| Short % of Shares Out | 6.59% |
| Short % of Float | 6.66% |
| Short Ratio (days to cover) | 5.68 |
Income Statement
In the last 12 months, BPMC had revenue of $434.42 million and -$128.05 million in losses. Loss per share was -$2.06.
| Revenue | 434.42M |
| Gross Profit | 421.48M |
| Operating Income | -275.95M |
| Pretax Income | -204.95M |
| Net Income | -128.05M |
| EBITDA | -262.13M |
| EBIT | -275.95M |
| Loss Per Share | -$2.06 |
Full Income StatementBalance Sheet
The company has $734.17 million in cash and $732.70 million in debt, giving a net cash position of $149.65 million or $2.36 per share.
| Cash & Cash Equivalents | 734.17M |
| Total Debt | 732.70M |
| Net Cash | 149.65M |
| Net Cash Per Share | $2.36 |
| Equity (Book Value) | 313.15M |
| Book Value Per Share | 4.93 |
| Working Capital | 597.19M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$242.15 million and capital expenditures -$8.37 million, giving a free cash flow of -$250.52 million.
| Operating Cash Flow | -242.15M |
| Capital Expenditures | -8.37M |
| Free Cash Flow | -250.52M |
| FCF Per Share | -$3.94 |
Full Cash Flow StatementMargins
Gross margin is 97.02%, with operating and profit margins of -63.52% and -29.48%.
| Gross Margin | 97.02% |
| Operating Margin | -63.52% |
| Pretax Margin | -29.33% |
| Profit Margin | -29.48% |
| EBITDA Margin | -60.34% |
| EBIT Margin | -63.52% |
| FCF Margin | n/a |
Dividends & Yields
BPMC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.11% |
| Shareholder Yield | -3.11% |
| Earnings Yield | -2.24% |
| FCF Yield | -4.37% |
Dividend DetailsAnalyst Forecast
The average price target for BPMC is $120.79, which is 34.00% higher than the current price. The consensus rating is "Buy".
| Price Target | $120.79 |
| Price Target Difference | 34.00% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 36.30% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BPMC has an Altman Z-Score of 1.12 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.12 |
| Piotroski F-Score | 3 |